Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. Our proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. The Rubedo leadership team is composed of industry leaders and pioneers in chemistry, technology, and the life sciences, with a deep bench of expertise in drug development and commercialization spanning from large pharma to biotech innovators. The company is based in Sunnyvale, CA.

California Institute for Regenerative Medicine

Khosla Ventures

Refactor Capital

The Longevity Fund

Shanda Group

Rubedo Life Sciences

Rubedo CEO Dr. Marco Quarta will be speaking at Longwood Healthcare Leaders panel on "Advancing Research into the Clinic" along with other leaders in the field, A. Stewart Campbell from Axial, Susan Hill from Mestag Therapeutics, Sunil Verma from AstraZeneca and Robert LaCaze from Mnemo Therapeutics. Reach out and meet us there, ahead of JPM Healthcare Conference week. 


Our CEO, Dr. Marco Quarta will be speaking at #BiotechShowcase during the J.P. Morgan HealthCare Conference Week, giving an update on our therapeutic pipeline and development. Come and join us, with CBO Ali Siam, to hear the exciting news on Monday January 8th at 10:00 am in Franciscan B (Ballroom Level). 

On January 9th, Dr. Quarta will be speaking on the panel dedicated to the  #ScienceOfLongevity along with other leading experts and founders of #LongevityMedicines companies Hanadie Yousef of Juvena Therapeutics; John Ramunas of Rejuvenation Technologies Inc. and Mark Kotter of @Clock.bio with the panel led by the fantastic Ed Saltzman of Lumanity. 

We hope to see you there!

Biopharmaceutical company focusing on developing therapeutics to extend healthspan by slowing, halting, or reversing diseases of aging.

Unity Biotechnology

Biotechnology company developing therapies to selectively destroy senescent cells, aiming to extend healthy human lifespan.

Oisin Biotechnologies

Biotechnology company focused on developing small molecule drugs to target senescent cells and age-related diseases.

Cleara Biotech

Rubedo Life is a company that focuses on leveraging machine learning and AI in drug discovery and molecular property prediction, with a strong emphasis on advancing human intelligence in the field of healthcare and pharmaceuticals.

Rubedo Life

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 4, 2024 6:44 PM	b98c90ea
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 6:44 PM	cacfb530
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	3731bd77
crunchbase profile	general
li profile	general	Mar 4, 2024 6:44 PM	35d94315
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 4, 2024 6:44 PM	5a98ad99
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:RUBEDOLIFE

Rubedo Life